| REVIEW ARTICLE |
|
| Year : 2020 | Volume
: 7
| Issue : 2 | Page : 86-96 |
|
|
Human vaccines industry in china, 2019: Part II
Prasanta Kumar Ghosh
Ex-Adviser, Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, India
Correspondence Address:
Dr. Prasanta Kumar Ghosh
Department of Biotechnology, Government of India; BlockC2B, Flat 5A, Janakpuri, New Delhi 110058, Delhi.
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mgmj.MGMJ_48_20
|
|
|
There are a large number of private manufacturers of vaccines in China. Most of the Chinese private companies manufacturing vaccines were established in the decade of 1990 and thereafter. Local investors came forward to set up manufacturing facilities in an environment of China’s growing demand for human vaccines and for exports. There are at present about 34 companies operating in the private sector, including MNCs. In this review, profiles of 25 private Chinese companies have been brought out. The turnover of vaccines manufactured in China is estimated at between US$3.50 and US$3.95 billion in 2019. Although the turnover of the vaccine industry was about 2.7%–3.1%, when compared to its pharmaceutical industry in value terms, it is a very important segment of healthcare infrastructure of the country. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
